期刊文献+

KIR-HLA基因多态性与散发性急性戊型肝炎的关系 被引量:7

Association between killer cell immunoglobulin- like receptor/human leukocyte antigen gene polymorphisms and sporadic acute hepatitis E
下载PDF
导出
摘要 目的探讨杀伤性免疫球蛋白样受体(KIR)及其配体人类白细胞抗原(HLA)的基因多态性与散发性急性戊型肝炎(AHE)的相关性。方法收集2015年8月-2016年9月期间于复旦大学附属公共卫生临床中心肝炎一科住院的AHE患者42例,另招募健康受试者30例作为对照组。提取入组对象外周血基因组DNA,采用序列特异性引物PCR法扩增KIR基因,并利用Sanger测序法对HLA进行基因分型,分析KIR-HLA分布与散发性AHE的关系。计数资料组间比较采用χ~2检验。结果两组均可检测到16种KIR基因(包括抑制型受体基因2DL1-3、2DL5、3DL1-3,激活型受体基因2DS1-5、3DS1,较特殊的抑制型/激活型受体基因2DL4,内参基因DRB1及假基因2DP1),同时HLA-B(包括HLA-Bw4、HLA-Bw6、HLA-Bw4/Bw6)、HLA-C(包括HLA-C1/C1、HLA-C1/C2、HLA-C2/C2)亦可检测。AHE患者中抑制型基因KIR 2DL3/2DL5/3DL2/3DL3出现的频率显著低于对照组(64.3%vs 93.3%,P<0.05;23.8%vs 56.7%,P<0.05;71.4%vs 100%,P<0.05;69.0%vs 100%,P<0.05);AHE患者HLA-C1/C2和3DL1/HLA-Bw4基因的出现频率低于对照组(19.0%vs 40.0%,P<0.05;45.2%vs 73.3%,P<0.05);另外,AHE患者中HLA-C1/C1基因出现的频率高于对照组(71.4%vs 46.7%,P<0.05)。结论抑制型基因KIR 2DL3/2DL5/3DL2/3DL3,HLA-C1/C1、C1/C2和3DL1/HLA-Bw4的基因分布差异可能与HEV感染导致散发性AHE有一定关系。 Objective To investigate the association between killer cell immunoglobulin-like receptor(KIR)/human leukocyte antigen(HLA) gene polymorphisms and sporadic acute hepatitis E(AHE).Methods A total of 42 AHE patients who were hospitalized in First Department of Hepatitis,Public Health Clinical Center Affiliated to Fudan University,from August 2015 to September 2016 were enrolled,and 30 healthy subjects were enrolled as control group.Genomic DNA was extracted from the peripheral blood,and PCR/sequence specific primer was used for the amplification of KIR gene.Sanger sequencing was used to determine the genotype of HLA,and the association between KIR-HLA distribution and sporadic AHE was analyzed.The chi-square test was used for comparison of categorical data between groups.Results A total of 16 KIR genes were detected in each group,including inhibitory receptor genes 2DL1-3,2DL5,and 3DL1-3,activating receptor genes 2DS1-5 and 3DS1,the special inhibitory/activating receptor gene 2DL4,internal reference gene DRB1,and pseudogene 2DP1,as well as HLA-B(including HLA-Bw4,HLA-Bw6,and HLA-Bw4/Bw6) and HLA-C(including HLA-C1/C1,HLA-C1/C2,and HLA-C2/C2),were also detected.Compared with the control group,the AHE group had significantly lower frequencies of inhibitory genes KIR 2DL3(64.3% vs 93.3%,P〈0.05),2DL5(23.8% vs 56.7%,P〈0.05),3DL2(71.4% vs 100%,P〈0.05),and 3DL3(69.0% vs 100%,P〈0.05),significantly lower frequencies of HLA-C1C2(19.0% vs 40.0%,P〈0.05) and 3DL1/HLA-Bw4(45.2% vs 73.3%,P〈0.05),and a significantly higher frequency of HLA-C1/C1 gene(71.4% vs 46.7%,P〈0.05).Conclusion The difference in the distribution of inhibitory genes KIR 2DL3,2DL5,3DL2,and 3DL3,HLA-C1C1/C1C2,and 3DL1/HLA-Bw4 may be associated with sporadic AHE caused by hepatitis E virus infection.
作者 陈冲 章树业 荀静娜 张玉玲 李微霞 卢川 陈良 CHEN Chong ZHANG Shuye XUN Jingna et al(Wenzhou Medical University, Wenzhou, Zhejiang 325000, Chin)
出处 《临床肝胆病杂志》 CAS 2017年第3期462-465,共4页 Journal of Clinical Hepatology
基金 国家重点基础研究发展计划"973计划"(2015CB554303) 上海申康医院发展中心市级医院新兴前沿技术联合攻关项目(SHDC12015129) 上海市科委"科技创新行动计划"医学与农业领域重点项目(13401902100)
关键词 肝炎 戊型 多态性 单核苷酸 受体 自然杀伤细胞 HLA抗原 基因型 hepatitis E polymorphism single nucleotide receptors natural killer cell HLA antigens genotype
  • 相关文献

参考文献1

二级参考文献34

  • 1REHERMANN B, BERTOLETTI A. Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C vi-rus infections [ J ]. Hepatotogy, 2015, 61 (2) : 712 - 721.
  • 2ASADULLAH K, STERRY W, VOLK HD. Interleukin -10 therapy -review of a new approach[J]. Pharmacol Rev, 2003, 55(2) : 241 -269.
  • 3NI G, WANG T, WALTON S, et al. Manipulating IL -10 sig- nalling blockade for better immunotherapy [J].Cell Immu- nol, 2015, 293(2) : 126 -129.
  • 4SARAIVA M, O'GARRA A. The regulation of IL -10 produc- tion by immune cells[J]. Nate Rev Immunol, 2010, 10(3) : 170 -181.
  • 5NG CT, OLDSTONE MB. IL -10: achieving balance during persistent viral infection[J].Curr Top Microbiol Immunol, 2014, 380: 129-144.
  • 6GABRYSOVA L, HOWES A, SARAIVA M, et al. The regula- tion of IL - 10 expression [ J ]. Curr Top Microbiol Immunol, 2014, 380: 157 -190.
  • 7D'ANDREA A, ASTE -AMEZAGA M, VALIANTE NM, et al. Intedeukin 10 (IL-10) inhibits human lymphocyte interferon gamma -production by suppressing natural killer cell stimula- tory factor/IL - 12 synthesis in accessory cells [J]. J Exp Med, 1993, 178(3): 1041 -1048.
  • 8MANNINO MH, ZHU Z, XIAO H, et al. The paradoxical role oflL-10 in immunity and cancer[J]. Cancer Lett, 2015, 367(2) : 103 -107.
  • 9SAXENA A, KHOSRAVIANI S, NOEL S, et al. Interleukin - 10 paradox: a potent immunoregulatory cytokine that has been difficult to harness for immunotherapy[ J ]. Cytokine, 2015, 74(1 ): 27 -34.
  • 10LUNEMANN S, MALONE DF, HENGST J, et al. Compro- mised function of natural killer cells in acute and chronic viral hepatitis[J]. J Infect Dis, 2014, 209(9): 1362-1373.

共引文献6

同被引文献47

引证文献7

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部